| Au-GSH-Dox | doxorubicin conjugated to glutathione-stabilized gold nanoparticles |
| Au-NPs AVMA |
gold nanoparticles American Veterinary Medical Association |
| BSA | bovine serum albumin |
| DDS | drug delivery system |
| DFS | disease free survival |
| FDA | Food and Drug Administration |
| FISS | feline injection-site sarcoma |
| HA | polysaccharide hyaluronan |
| HA-Pt | cisplatin polysaccharide hyaluronan |
| IL-2 | interleukin 2 |
| IL-12 | interleukin 12 |
| IV | intravenous |
| LC | liposomal clodronate |
| LDC | liposome-DNA complexes |
| LLD | low sensitive liposome doxorubicin |
| L-MTP-PE | Liposomal Muramide-Tripeptide-phosphatidylethanolamine |
| L-VCR | liposome encapsulated vincristine |
| MDR | multi drug resistance |
| MFI | metastasis free interval |
| OS | overall survival |
| OSA | osteosarcoma |
| PEG | polyethylene glycol |
| P-gp | P-glycoprotein |
| PLGA | poly (lactic-co-glycolic acid) |
| PPPS | palmar-plantar erythrodysesthesia |
| RES | reticulo-endothelial system |
| ST | survival time |
| TAM | tumour associated macrophages |